Motus GI Holdings Inc (NASDAQ:MOTS) has been given an average recommendation of “Buy” by the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $10.50.
A number of research analysts recently weighed in on MOTS shares. Oppenheimer set a $10.00 price target on shares of Motus GI and gave the company a “buy” rating in a research report on Thursday, March 28th. Zacks Investment Research raised shares of Motus GI from a “hold” rating to a “buy” rating and set a $4.50 price target on the stock in a research report on Tuesday, January 29th.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Perceptive Advisors LLC lifted its position in shares of Motus GI by 14.2% during the fourth quarter. Perceptive Advisors LLC now owns 3,210,542 shares of the company’s stock valued at $9,984,000 after purchasing an additional 400,000 shares in the last quarter. Nantahala Capital Management LLC purchased a new stake in Motus GI during the fourth quarter worth about $1,555,000. RTW Investments LP increased its holdings in Motus GI by 672.5% during the fourth quarter. RTW Investments LP now owns 459,478 shares of the company’s stock worth $1,429,000 after buying an additional 400,000 shares during the last quarter. Lombard Odier Asset Management USA Corp increased its holdings in Motus GI by 78.6% during the third quarter. Lombard Odier Asset Management USA Corp now owns 125,000 shares of the company’s stock worth $638,000 after buying an additional 55,000 shares during the last quarter. Finally, Mesirow Financial Investment Management Inc. purchased a new stake in Motus GI during the first quarter worth about $350,000. 37.01% of the stock is currently owned by institutional investors.
Motus GI (NASDAQ:MOTS) last released its quarterly earnings results on Wednesday, March 27th. The company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.02). Analysts predict that Motus GI will post -1 earnings per share for the current year.
About Motus GI
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.